Implementing AI can improve clinical operations efficiency for better outcomes. Doing this successfully inevitably influences company processes and structure. Managing the risks of an organizational transition is as vital as obtaining funding and controlling costs. I facilitate a client assessment of transition risks and planning of responses to contingencies.
Quality is an ongoing imperative in the highly regulated biopharma industry. Defining quality objectives is essential for success, whether AI adoption is driven by time, cost, or risks. Setting quality objectives involves key stakeholders and resolution of competing priorities. I help organizations focus on identifying goals and building a culture that can realize them.